Molecular Profiling-based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 10 Jul 2019
At a glance
- Drugs Adavosertib (Primary) ; Carboplatin (Primary) ; Everolimus (Primary) ; Temozolomide (Primary) ; Trametinib (Primary) ; Veliparib (Primary)
- Indications Solid tumours
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms MPACT
- 08 Jul 2019 Planned primary completion date changed from 5 May 2019 to 5 May 2020.
- 25 Mar 2019 Status changed from suspended to recruiting.
- 08 Jan 2018 Status changed from recruiting to suspended.